
Nightscout as a service. A legal minefield?
When Heroku removed their free tier, many people started to ask questions about what they should do next. There were a number of options. Pay […]
When Heroku removed their free tier, many people started to ask questions about what they should do next. There were a number of options. Pay […]
As we have espoused here on Diabettech in the past, not all clinical trials for CGM systems are equal. To this, end, we’re now proud […]
Adding measurements to the SiBio CKM to determine how it works.
What impact does a botched rollout of an app update have on a CGM provider?
The world’s first Continuous Ketone Monitor from SiBio. What does it do and how relevant is it to diabetes?
As they go, this one looks quite smart, and appears to be running a slightly different operating system to all of the others that I’ve […]
Which seems like a suitable metaphor for a field test of an experimental algorithm that doesn’t require mealtime bolusing and uses stepcount to mediate how […]
Novo Nordisk’s acquisition of Biocorp demonstrates how insulin manufacturers are looking to take the next step in optimising insulin delivery, opening up better access to AI techniques for MDI users.
Another non-invasive CGM in a Smartwatch shows off its wares.
It turned out to be as bad as you’d expect.
Learning about step counts as an input in AID systems. What does and doesnt work, and what could be better?
Copyright © 2023 | WordPress Theme by MH Themes